A NOVEL SYNERGISTIC COMPOSITION FOR THE TREATMENT OF VISCERAL LEISHMANIASIS Abstract: The present invention discloses the antileishmanial role of Withaferin-A that can be used alone or in combination with existing antileishmanial drugs like Miltefosine to enhance the efficacy of the existed drug through the synergistic effect in treating Visceral Leishmaniasis (VL).